MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy
Condition(s):Drug Resistant EpilepsyLast Updated:October 18, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Drug Resistant EpilepsyLast Updated:October 18, 2022Not yet recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:June 23, 2021Not yet recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:May 23, 2023Recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:September 6, 2023Recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:January 19, 2023Recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:May 16, 2023Recruiting
Condition(s):Drug Resistant Epilepsy; Ketogenic Diet; Feasibility; Tolerability; Efficacy; ChildrenLast Updated:January 26, 2023Completed
Condition(s):Drug Resistant EpilepsyLast Updated:October 10, 2022Recruiting
Condition(s):Drug Resistant EpilepsyLast Updated:July 17, 2017Unknown status
Condition(s):Epilepsy; Intermittent FastingLast Updated:August 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.